POST Online Media Lite Edition



 

Zinc oxide for young pigs to be phased out in Europe

Staff Writer |
The European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) has recommended to the European Commission that medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs should be withdrawn from the market.

Article continues below






At present, EU member states have authorised several medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs.

The medicinal products are mixed into the feed and given to young pigs in connection with the transition from liquid feed to solid feed. However, there are concerns that these medicinal products may have a long-term environmental impact.

Consequently, the CVMP recommended the withdrawal of all medicinal products containing zinc oxide for young pigs at its meeting held on December 6-8, 2016.

The European Commission will make the final decision on the basis of the CVMP’s recommendation.

At the same meeting, the CVMP decided to send a letter to the European Commission with a recommendation that the European Commission considers an appropriate phasing-out period, possibly after a meeting with the stakeholders.

A phasing-out period is recommended because an immediate stop would result in increased incidence of disease in young pigs and thus increased consumption of antibiotics.


What to read next

English pig numbers fell by 3.6% in 2015
Number of pigs in Austria decreased, sheep and goats stay strong
German pig herd decline raises hope of tightening supplies